Advertisement
General and central obesity are associated with breast cancer risk

General, Central Obesity Linked to Specific Breast Cancer Risk

0
General obesity, indicated by BMI, more strongly linked to ER+/PR+ subtype
For patients undergoing liver surgery

Extended Thromboprophylaxis Safe, Effective After Liver Surgery

0
Severe complication rate 5.6 percent, with no 90-day mortalities
Monthly feedback significantly improves colonoscopy quality measures

Monthly Feedback Linked to Improved Colonoscopy Quality

0
But no improvement observed with quarterly feedback
The American College of Physicians does not support the legalization of physician-assisted suicide

ACP Does Not Support Legalization of Assisted Suicide

0
Legalization would affect trust in the patient-physician relationship, and in the medical profession
The fibroblast growth factor receptor 3 transforming acidic coiled-coil containing protein 3 (TACC3) gene fusion recruits endogenous TACC3 away from the mitotic spindle

New Link Seen Between Gene Fusion and Bladder Cancer

0
Previously overlooked section of fusion found to negatively impact cancer cells, researchers say
Programmed death-ligand 1 is primarily expressed in metastatic colorectal cancer lesions

PD-L1 Mainly Expressed in Metastatic CRC Lesions

0
Overall, 81.8 percent of metastatic CRCs and 40.9 percent of primary lesions had PD-L1 expression
For people living with HIV

Expected Burden of Lung Cancer High for People Living With HIV

0
PLWH who adhere to antiretroviral tx but smoke are substantially more likely to die from lung cancer
Spin in biomedical literature (also referred to as "science hype") is prevalent

‘Science Spin’ Found Prevalent in Biomedical Literature

0
Nature of spin varies, with highest variability in prevalence of spin seen in trials
Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults with relapsed follicular lymphoma who have received at least two prior treatments with certain other drugs.

FDA Approves Aliqopa for Follicular Lymphoma

0
Aliqopa, a kinase inhibitor, blocks several enzymes that promote cell growth
Sepsis is present in 6 percent of adult hospitalizations

EHR Data May Beat Claims Data in Assessing Sepsis Incidence

0
Based on clinical data, no change seen in incidence of sepsis, combined outcome of death or discharge